Japan Pharmaceutical Association

What Japan Pharmaceutical Association does

Japan Pharmaceutical Association (公益社団法人日本薬剤師会, JPA) is the national professional association for pharmacists in Japan, founded in 1926 and headquartered in Tokyo (Shinjuku-ku). It serves as the recognized representative body of Japan's pharmacist profession, with approximately 101,000 members (~31% of the ~323,000 licensed pharmacists nationwide) drawn predominantly from community pharmacies (78.8%), with smaller cohorts from hospital/clinic, wholesale, administrative, manufacturing, and academic roles. JPA operates through a federation of 47 prefectural pharmacist associations that provide full nationwide coverage, and is the statutory counterpart to the Ministry of Health, Labour and Welfare (MHLW) and PMDA on pharmacy policy, the separation of prescribing and dispensing (医薬分業), and public health initiatives.

JPA's core technology and product portfolio centers on digital pharmacy infrastructure and credentialing. It operates the HPKI (Healthcare Professional PKI) authentication bureau, issuing pharmacist qualification certificates (HPKI cards) and a second electronic certificate for smartphone-based digital signatures, jointly with the Japan Medical Association and MEDIS. It runs the JPALS lifelong learning and certification platform (with reforms effective April 2026), the e-okusuri electronic medication notebook, and the N-Bridge pharmacy DX platform and NB Station terminal developed in partnership with Farmmo Co., Ltd. for electronic prescription transmission. The Nichiatsu App, released in 2026, provides member-facing services and notifications. Supporting services include professional training platforms, insurance and welfare programs, an academic degree-acquisition support site, and the Japan Pharmaceutical Association Journal.

JPA's business model is membership-dues-driven. Regular Member A (pharmacist managers) and Supporting Member A (pharmacy operators) pay 18,000 yen/year; Regular Member B and Supporting Member B pay 7,000 yen/year; special student members are free. Additional revenue comes from training seminars (3,000–5,000 yen per session, with differential member/non-member pricing), conferences, and digital services. As a public interest incorporated association, JPA is governed by elected representatives from its prefectural chapters and is not owned by any investor; financial details are not publicly disclosed.

Name

Japan Pharmaceutical Association

Legal name

公益社団法人日本一冊会

Website

https://nichiyaku.or.jp

Company type

Private

Founded year

1926

Operating status

Operating

Headcount range

1–10 employees

Short description

Japan Pharmaceutical Association is the national professional association for pharmacists in Japan, representing ~101,000 members (about 31% of licensed pharmacists) and operating credentialing, digital pharmacy, and lifelong learning services through 47 prefectural chapters.

Ownership category

akta.pro rank

Product category

Professional Pharmacy Association Services

NAICS

Professional, Scientific, and Technical Services (541)

akta.pro primary industry

Controlled Substances & Pharmacy Regulation Authorities (HLAJACAI)

akta.pro secondary industry

Schools of Pharmacy (EDAHAGAE)

Keywords

• Pharmacist professional association
• Pharmacy digital transformation
• Pharmacist lifelong learning
• Electronic prescription services
• Pharmacy certification systems

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Membership Fees: The Japan Pharmaceutical Association generates revenue through annual membership fees. Regular member (A) fees are 18,000 yen per year for managers or those wishing to contribute to the association. Regular member (B) fees are 7,000 yen per year. Supporting members include pharmacy operators at 18,000 yen, and pharmaceutical wholesale/retail personnel and pharmacy students at 7,000 yen. Special student members are free of charge.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Core offering

The Japan Pharmaceutical Association is the national professional body for pharmacists in Japan, providing membership services (insurance, welfare, professional development), lifelong learning and certification through JPALS, digital pharmacy platforms (N-Bridge, e-okusuri, e-薬Link, e-薬SCAN), the HPKI electronic qualification card system for digital signatures, the 日薬モバイル app, the monthly Japan Pharmaceutical Association Journal, and policy advocacy for the pharmacy profession.

Product overview

Japan Pharmaceutical Association operates as a professional pharmacists' organization offering a comprehensive digital service ecosystem. The core offerings include the Nichiatsu App mobile application, e-okusuri electronic medication notebook, N-Bridge pharmacy DX platform, JPALS lifelong learning system, and HPKI pharmacist qualification cards with digital signature capabilities. Additional services encompass e-kusulink and e-kusulink for pharmacy connectivity, the Japan Pharmaceutical Association Journal in digital format, email newsletter services, training platforms, and academic degree support. The association also provides member benefits including insurance programs (pharmacist liability insurance, cyber insurance) and various welfare services. The portfolio operates through a platform-plus-services model centered on pharmacist professional development, digital pharmacy services, and credential management.

Differentiator

Problem solved

Functional benefit

Products and services

• JPALS (Japan Pharmaceutical Association Lifelong Learning System) Professional development and certification platform for pharmacists in Japan providing training records, credential management, and certified pharmacist recognition. Reforms to the JPALS certification pharmacist system took effect in April 2026. Used by pharmacists seeking continuing professional development and formal recognition.
• HPKI Card (Pharmacist Qualification Card) Healthcare Professional PKI IC card issued by the Japan Pharmaceutical Association Authentication Bureau, serving as electronic proof of pharmacist national qualification and enabling electronic signatures and authentication functions for medical ICT systems. Used by licensed pharmacists requiring compliant digital identity for electronic prescriptions.
• e-okusuri (e-お薬手帳) Electronic Medication Notebook Electronic medication record service allowing patients and pharmacists to track medication history across different pharmacies, supporting better medication management and health coordination. Used by patients receiving prescription medications at community pharmacies in Japan.
• N-Bridge Pharmacy DX Platform Pharmacy digital transformation foundation platform developed in partnership with Farmmo Co., Ltd., providing prescription information transmission terminals (NB Station) for medical institution settings and enabling pharmacy DX. Used by community pharmacies seeking digital infrastructure for prescription management.
• 日薬アプリ (Nichiatsu App) Official mobile application released by Japan Pharmaceutical Association for member pharmacists to access member services, receive notifications, and manage their professional activities. Used by JPA member pharmacists.
• HPKI Second Electronic Certificate Secondary electronic certificate for pharmacists enabling HPKI electronic signatures via smartphone using biometric authentication or My Number Card, providing backup capability when the HPKI physical card is unavailable. Used by licensed pharmacists needing remote digital signature capability.
• Japan Pharmaceutical Association Training Platform Training platform offering professional development programs, seminars, and educational resources for pharmacist continuing education. Used by JPA members and non-members (with differentiated pricing) seeking continuing professional education.

Named customers3 records

Segments7 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eleven partnerships are on record, tiered major, minor and core.

• Farmmo Co., Ltd. (株)ファルモmajorTechnology or Integration · 8 October 2025JPA partnered with Farmmo to develop and provide N-Bridge, a pharmacy DX platform, and NB Station, an electronic prescription information transmission terminal for medical institution settings. This partnership aims to modernize pharmacy operations through digital infrastructure.
• Vehicle Supply Partnership for Disaster ResponseminorStrategic or Co-development Partner · 22 April 2025JPA signed a cooperation agreement for vehicle supply related to pharmacist disaster support activities, enabling rapid deployment of pharmacists during emergencies.
• FIP (International Pharmaceutical Federation)coreStrategic or Co-development PartnerThe Japan Pharmaceutical Association is a member of FIP, the global pharmacy organization. Through this membership, JPA participates in international pharmacy profession development, standards setting, and collaborative initiatives with pharmacy associations worldwide.
• WPPF (Western Pacific Pharmaceutical Forum)coreStrategic or Co-development PartnerJPA participates in the WPPF, the Western Pacific regional pharmacy forum, collaborating with pharmacy associations across the Asia-Pacific region on pharmaceutical care standards and professional development.
• FAPA (Federation of Asian Pharmaceutical Associations)coreStrategic or Co-development PartnerJPA participates in FAPA, the Federation of Asian Pharmaceutical Associations, working with regional counterparts on pharmacy profession advancement and healthcare initiatives. JPA provides student member discounts for FAPA2026 conferences.
• PMDA (Pharmaceuticals and Medical Devices Agency)majorGTM or Marketing PartnerJPA collaborates with PMDA on drug safety information dissemination, medical device safety campaigns, and regulatory communications to pharmacists. Joint initiatives include drug safety awareness campaigns.
• Japan Medical Association (日本医師会)coreStrategic or Co-development PartnerJPA works with the Japan Medical Association and Japan Dental Association as part of the three healthcare professional organizations, collectively addressing medical policy and healthcare system improvements.
• Japan Hospital Pharmacist Association (日本病院一冊会)majorStrategic or Co-development PartnerCollaboration on hospital and clinical pharmacy practice standards, joint training initiatives, and healthcare policy advocacy.
• MEDIS (Medical Information Systems Development Center)coreTechnology or IntegrationJPA collaborates with MEDIS on the HPKI (Healthcare Professional PKI) system and remote signature services for pharmacists. The HPKI authentication bureau is operated jointly with the Japan Medical Association and MEDIS.
• Japan Pharmaceutical Association Training Center (日本一冊研修センター)coreStrategic or Co-development PartnerCo-organizer of training programs and certification systems including the JPALS (Japan Pharmaceutical Association Lifelong Learning System) and certified pharmacist recognition programs.
• Ministry of Health, Labour and Welfare (厚生労働省)coreOthersJPA works closely with MHLW on pharmaceutical policy, pharmacy practice regulations, drug supply security, and public health initiatives. The association provides policy recommendations and receives guidance on pharmacy practice standards.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Japan Medical Association: The national professional association for physicians in Japan, often collaborating with JPA on healthcare policy. Comparable as a parallel healthcare professional association with similar structure and government ties, though serving physicians rather than pharmacists.

Others

• Federation of Asian Pharmaceutical Associations: The regional federation of Asian pharmacist associations of which JPA is a member. Comparable as an umbrella organization coordinating national pharmacy associations, providing a different scope but related mission.
• International Pharmaceutical Federation: The global body representing pharmacy, of which JPA is a member. Comparable as an international counterpart operating one organizational layer above national pharmacist associations.

Direct peers

• Japan Hospital Pharmacist Association: The specialized Japanese association for hospital pharmacists, focused on inpatient pharmacy, clinical pharmacy, and team-based medical care. Closely comparable as a parallel Japanese pharmacist body with overlapping membership.
• American Pharmacists Association: The US national professional association for pharmacists, providing continuing education, advocacy, and member services. Directly comparable as the most analogous national pharmacist membership organization in another major market.
• Royal Pharmaceutical Society: The professional body for pharmacists in Great Britain, combining membership, professional development, and regulatory-adjacent functions. Comparable as a national pharmacist body with both membership and standards-setting roles.
• American Society of Health-System Pharmacists: The US professional association for hospital and health-system pharmacists, focused on clinical practice, training, and standards. Comparable in mission to JPA's hospital pharmacist engagement and JPALS clinical certification efforts.
• Pharmaceutical Society of Australia: The peak professional body for Australian pharmacists, offering education, advocacy, and member services. Directly comparable as a national pharmacist association in a developed market.
• Canadian Pharmacists Association: The national voice of Canadian pharmacists, providing advocacy, professional development, and member resources. Comparable as a national pharmacist membership and advocacy organization.

Regional players

• Korean Pharmaceutical Association: The national professional association for pharmacists in South Korea, with a similar mandate around advocacy, training, and member services. Comparable as a peer national pharmacist body in an adjacent Asian market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/japan-pharmaceutical-association

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Japan Pharmaceutical Association